Dr. Richard C Ballantyne, DO Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 215 E Hawaii Ave, Nampa, ID 83686 Phone: 208-364-3000 |
Dr. Eric Paul Kendall, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1512 12th Ave Rd, Nampa, ID 83686 Phone: 208-463-5100 |
William R England, M.D Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 215 E Hawaii Ave, Nampa, ID 83686 Phone: 208-463-3234 Fax: 208-463-3044 |
Thomas Ronay, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 85 S Middleton Rd, Nampa, ID 83651 Phone: 208-505-2800 |
John Mullins, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1115 12th Ave Rd, Nampa, ID 83686 Phone: 208-498-1080 |
Dr. Mitchell D Long, DO Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 1512 12th Ave Rd, Nampa, ID 83686 Phone: 208-463-5100 |
Dr. Roger Keith Ottman, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1512 12th Ave Rd, Nampa, ID 83686 Phone: 208-463-5100 |
Elizabeth A Davis, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 215 E Hawaii Ave, Nampa, ID 83686 Phone: 208-463-3000 Fax: 208-463-3064 |
Dr. Tyler James Harris, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1510 12th Ave Rd Ste 100, Nampa, ID 83686 Phone: 208-498-1333 |
News Archive
Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals Inc. has launched Oxycodone and Aspirin Tablets USP, 4.8355 mg/325 mg, based on an agreement with licensing partner Coastal Pharmaceuticals.
The low divergence of near-identical genomes that are sequenced in short periods presents a statistical challenge that is not addressed by methods available currently. In a recent bioRxiv** paper, Ales Varabyou et al. from John Hopkins University present an efficient method designed to detect recombination and reassortment events between clades of viral genomes – a new algorithm called ‘Bolotie'.
Mylan Inc. today announced that its subsidiary Matrix Laboratories Limited has received final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application for Simvastatin Tablets USP, 5 mg, 10 mg, 20 mg, 40 mg and 80 mg, the generic version of Merck & Co.'s Zocor Tablets, a treatment for high cholesterol. The product will be distributed by Mylan Pharmaceuticals Inc.
A new preparation of an omega-3 polyunsaturated fatty acid found naturally in fish, offers hope for thousands of patients at risk of developing an inherited form of bowel cancer, a new study shows.
An antibody appears to make a big difference between multiple sclerosis and other disorders affecting the protective myelin sheath around nerve fibers, report Tohoku University scientists and colleagues in the journal Brain.
› Verified 6 days ago